A Phase 2 Randomized Controlled Trial of the Efficacy and Safety of Cannabidivarin as Add-on Therapy in Participants with Inadequately Controlled Focal Seizures
Resumen
Palabras clave
Fármaco antiepiléptico; Cannabinoide; Epilepsia
Citación recomendada
Brodie MJ, Czapinski P, Pazdera L, Sander JW, Toledo M, Napoles M, et al. A Phase 2 Randomized Controlled Trial of the Efficacy and Safety of Cannabidivarin as Add-on Therapy in Participants with Inadequately Controlled Focal Seizures. Cannabis Cannabinoid Res. 2021 Dec;6(6):528–536.
Audiencia
Professionals
Usar este identificador para citar y/o enlazar este documento
https://hdl.handle.net/11351/7720Este elemento aparece en las siguientes colecciones
- HVH - Articles científics [2970]
El ítem tiene asociados los siguientes ficheros de licencia: